Search Results Search Sort by RelevanceMost Recent In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004; 6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408. Policy Forum Aug 2004 Brain Death: At Once "Well Settled" and "Persistently Unresolved" Robert Truog, MD The use of neurological criteria to determine brain death has ethical implications for prospective organ donors. Virtual Mentor. 2004; 6(8):357-359. doi: 10.1001/virtualmentor.2004.6.8.pfor1-0408. State of the Art and Science Aug 2004 Diagnosing The Permanent Vegetative State Ronald Cranford, MD Neurologists need to understand and be able to identify the most distinguishing features of permanent vegetative state. Virtual Mentor. 2004; 6(8):350-352. doi: 10.1001/virtualmentor.2004.6.8.cprl1-0408. State of the Art and Science Oct 2004 Surgery for Bowel Obstruction in Ovarian Cancer Jennifer Reenan, MD Palliative surgery can be considered for terminally ill patients with bowel obstruction if the patient is likely to benefit from the surgery. Virtual Mentor. 2004; 6(10):449-451. doi: 10.1001/virtualmentor.2004.6.10.cprl1-0410. Case and Commentary Oct 2004 The Unnoticed Mole Avram Kraft, MD Surgeons should not make medical decisions for a patient while the patient is under anesthesia. Virtual Mentor. 2004; 6(10):436-437. doi: 10.1001/virtualmentor.2004.6.10.ccas1-0410. Case and Commentary Oct 2004 The Reluctant Resident Jeffrey L. Ponsky, MD Surgery residents should always answered truthfully when asked by patients about their experience with surgical procedures. Virtual Mentor. 2004; 6(10):438-439. doi: 10.1001/virtualmentor.2004.6.10.ccas2-0410. State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004; 6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411. Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004; 6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411. In the Literature Nov 2004 Maintaining Integrity in Industry-Sponsored Research Alison Bickford Many ethical and legal issues arise when academic medical research is sponsored by pharmaceutical companies. Virtual Mentor. 2004; 6(11):490-493. doi: 10.1001/virtualmentor.2004.6.11.jdsc2-0411. Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004; 6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411. Pagination First page « First Previous page ‹ Previous … Page 47 Page 48 Page 49 Page 50 Current page 51 Page 52 Page 53 Page 54 Page 55 … Next page Next › Last page Last »
In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004; 6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408.
Policy Forum Aug 2004 Brain Death: At Once "Well Settled" and "Persistently Unresolved" Robert Truog, MD The use of neurological criteria to determine brain death has ethical implications for prospective organ donors. Virtual Mentor. 2004; 6(8):357-359. doi: 10.1001/virtualmentor.2004.6.8.pfor1-0408.
State of the Art and Science Aug 2004 Diagnosing The Permanent Vegetative State Ronald Cranford, MD Neurologists need to understand and be able to identify the most distinguishing features of permanent vegetative state. Virtual Mentor. 2004; 6(8):350-352. doi: 10.1001/virtualmentor.2004.6.8.cprl1-0408.
State of the Art and Science Oct 2004 Surgery for Bowel Obstruction in Ovarian Cancer Jennifer Reenan, MD Palliative surgery can be considered for terminally ill patients with bowel obstruction if the patient is likely to benefit from the surgery. Virtual Mentor. 2004; 6(10):449-451. doi: 10.1001/virtualmentor.2004.6.10.cprl1-0410.
Case and Commentary Oct 2004 The Unnoticed Mole Avram Kraft, MD Surgeons should not make medical decisions for a patient while the patient is under anesthesia. Virtual Mentor. 2004; 6(10):436-437. doi: 10.1001/virtualmentor.2004.6.10.ccas1-0410.
Case and Commentary Oct 2004 The Reluctant Resident Jeffrey L. Ponsky, MD Surgery residents should always answered truthfully when asked by patients about their experience with surgical procedures. Virtual Mentor. 2004; 6(10):438-439. doi: 10.1001/virtualmentor.2004.6.10.ccas2-0410.
State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004; 6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411.
Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004; 6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411.
In the Literature Nov 2004 Maintaining Integrity in Industry-Sponsored Research Alison Bickford Many ethical and legal issues arise when academic medical research is sponsored by pharmaceutical companies. Virtual Mentor. 2004; 6(11):490-493. doi: 10.1001/virtualmentor.2004.6.11.jdsc2-0411.
Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004; 6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411.